Tag: travellers’ diarrhea

The U S Food and Drug Administration (USFDA) has approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travellers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. “Travellers’ diarrhea affects millions of people each year and having treatment options for this condition can help reduce symptoms of the condition,” said Edward Cox, M D, M P H, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. Travellers’ diarrhea is the most common travel-related illness, affecting an estimated ... Read more